Vatiquinone Expanded Access Protocol

Summary

The purpose of this study is to provide participants who successfully completed the study titled "An Open-label, Safety Study for Previously Treated Vatiquinone (PTC743) Subjects With Inherited Mitochondrial Disease" with liquid Vatiquinone through an intermediate patient population expanded access protocol.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications